I3tk - International Institute of Innovation and Technology

  Over the past ten years or so, there has been an increasing use of stem cells in the treatment of various health-related issues or disorders. Stem cell therapy for blood disorders has been successfully used for non-blood disorders. Extensive research by many health research institutes around the world has shown that mesenchymal stem cells (MSCs) provide a promising solution for the treatment and regrowth of human tissues. It is due to their ability to differentiate into multiple cell types, self-renew, proliferate outside the body for extended periods, have paracrine properties, and regulate the immune system. MSCs are advantageous in that they can nurture the growth and diversification of other stem cells, in addition to discharging bioactive molecules essential to tissue repair. Owing to these beneficial qualities, MSCs are regarded as having a considerable therapeutic function in the medical practices. As such, we herein reviewed the most current trials conducted to assess the

  The month of "June" is identified as Cancer Immunotherapy Research Awareness Month. This year (2023) marks a decade since cancer immunotherapy gained its first acknowledgment as a notable "breakthrough of the year" by science magazine in 2013. According to studies, more than thirty cancer types are treatable with immunotherapy, and the objective of this awareness month is to expand this figure and provide life-saving treatments to more individuals dealing with cancer. How is Cancer Targeted by Immunotherapy? Conventional approaches by a clinical research organization to combat cancer, such as radiation therapy and chemotherapy tend to bring about distressing physical and emotional repercussions. Unfortunately, their efficacy in treating metastatic cancers is restrained frequently. Furthermore, these treatment methods seldom lead to a permanent solution as patients may experience relapses or develop resistance to the treatment. Immunotherapy presents a pro

In the domain of clinical studies, a significant shift is occurring as decentralized clinical trials (DCTs) revolutionize the approaches employed by investigators during research. Ground breaking technologies and clever tactics for managing trials have paved the way for a  clinical research organization   in clinical exploration. This article will examine the impact research firms have made in DCTs while shedding light on the remarkable progress achieved in the recent years. Decentralized Clinical Trials Using AI Solutions  Nowadays, health tech enterprises are concentrating on developing AI-driven solutions for distributed clinical trials. These platforms primarily target patient enrolment, trial practicability, and site determination by evaluating organized and disorganized real-world information from electronic medical databases and different other sources. Leveraging natural language processing (NLP) and advanced machine learning techniques, these firms' AI-driven platfor